Prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis
“Prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis”, vol. 15, p. -, 2016.,
This meta-analysis study aimed to investigate the correlation between CD44-positive cancer stem cells (CSCs) and clinicopathological features and its effect on the survival of ovarian cancer patients. A comprehensive literature search in the electronic databases, including PubMed, EMBASE, and Wanfang (up to December 1, 2015), was conducted. Publications assessing the clinical or prognostic significance of CD44 expression in ovarian cancer were identified and reviewed until December 1, 2015.